2021 iBRCAf Program

13 August 2021

International BRCA forum 2021

14:30 - 14:35

Welcome Note
Joanne Ngeow | Singapore
Shaheenah Dawood | United Arab Emirates
Shona Nag | India

14:35 - 14:50

Pre-Conference Session: Cancer Germline Convergence and Divergence Cancer Predispositions
Shona Nag | India
Ghassan Abou-Alfa | USA
Cheng-Har Yip | Malaysia

14:50 - 15:05

Pre-Conference Session: BRCA Testing in Asia : Challenges and Pitfalls
Ava Kwong | Hong Kong
Shona Nag | India
Cheng-Har Yip | Malaysia

15:05 - 15:15

Pfizer Symposium: Introduction
Lee Soo Chin | Singapore

15:15 - 15:30

Pfizer Symposium: Management of ER+ HER2-ve mBC - Navigating clinical studies and Real -World Experience in first line treatment
Lee Soo Chin | Singapore
Janice Tsang | Hong Kong

15:35 - 15:50

Session 1: Back to Basics: Targeting the Homologous Recombination Pathway in Solid Tumors
Elias Obeid | USA
Joanne Ngeow | Singapore
Christina Galvez | Philippines

15:50 - 16:05

Session 1: Back to Basics: Should All Patient with Advanced Solid Tumors be Offered Genomic Testing?
Joanne Ngeow | Singapore
Lee Soo Chin | Singapore
Christina Galvez | Philippines

16:05 - 16:20

Session 1: Back to Basics: Clinical Impact of Multiplatform Tumor Profiling and Machine Learning / AI – Supported by Caris
Joanne Ngeow | Singapore
Christina Galvez | Philippines
Vasanti Natarajan | Switzerland

16:20 - 16:30

Session 1: Back to Basics: Patient Talk
Joanne Ngeow | Singapore
Christina Galvez | Philippines

16:30 - 16:35

AstraZeneca Symposium: New Decade More Precision in the Management of DDR Driven Women Cancers: Welcome and Introductions
See Hui Ti | Singapore

16:35 - 16:50

AstraZeneca Symposium: Clinical Value of DDR Genetic Testing in Women´s Cancers
See Hui Ti | Singapore
Reinhard Buttner | Germany

16:50 - 17:05

AstraZeneca Symposium: What, Who, When to Test to Optimize Outcomes of Women Cancers?
See Hui Ti | Singapore
Frederik Marmé | Germany

17:05 - 17:15

Q & A
See Hui Ti | Singapore
Reinhard Buttner | Germany
Frederik Marmé | Germany

17:15 - 17:30

Session 2: Targeting Therapy in Breast Cancer: Evolving Role of PARPi in Early Stage Breast Cancer
Karmen Wong | Singapore
Mark Robson | USA
Mastura Md Yusof | Malaysia

17:30 - 18:00

Session 2: Targeting Therapy in Breast Cancer: Breast Cancer Molecular Tumor Board
Elias Obeid | USA
Lee Soo Chin | Singapore
Omalkhair A. Abulkhair | Saudi Arabia
Shona Nag | India
Yeon Hee Park | Korea South
Bhawna Sirohi | India
Tira Tan | Singapore
Elaine Lim | Singapore
Mastura Md Yusof | Malaysia

18:05 - 18:20

Session 3: Targeting Therapy in Ovarian Cancer: PARP Inhibitors in 3rd Line and Platinum Resistant Ovarian Cancer - What is the Data?
John Chia | Singapore
Pamela Patdu | Philippines
Valerie Heong | Singapore

18:20 - 18:50

Session 3: Targeting Therapy in Ovarian Cancer: Gynae Cancer Molecular Tumor Board
Ka-Yu Tse | Hong Kong
Mohsen Mokhtar | Egypt
Pamela Patdu | Philippines
Jack Chan | Singapore
Valerie Heong | Singapore

18:50 - 19:05

Session 4: Targeting Therapy in Pancreatic Cancer: Evolving Role of BRCA Testing and PARPi Therapy in Pancreatic Cancer
Golan Talia | Israel
Chiang Jianbang | Singapore
Joycelyn Lee  | Singapore

19:05 - 19:35

Session 4: Targeting Therapy in Pancreatic Cancer: Pancreatic Cancer Molecular Tumor Board
Nitesh Rohtagi | Singapore
Golan Talia | Israel
Bhawna Sirohi | India
Chiang Jianbang | Singapore
Joycelyn Lee  | Singapore
Choo Su Pin | Singapore

19:35 - 19:50

Session 5: Targeting therapy in Prostate Cancer: Sequencing Therapy with PARPi in Prostate Cancer
Ravindran Kanesvaran | Singapore
Darren Poon | Hong Kong

19:50 - 20:20

Session 5: Targeting therapy in Prostate Cancer: Prostate Cancer Molecular Tumor Board
Ravindran Kanesvaran | Singapore
Kumar Prabhash | India
Jae Young Joung | Korea South
Johan Chan | Singapore
Tanuja Rajasekaran | Singapore
Melvin Chua | Singapore

20:20 - 20:25

Closing Remarks
Shaheenah Dawood | United Arab Emirates